UnknownNot Applicable

Non-Interventional Consecutive and Prospective Study of e.Motion® PS Pro Prosthesis in the Total Knee Artroplasty

France140 participantsStarted 2016-05-26

Plain-language summary

This post-market clinical follow-up study intends to investigate the survival rate at 5 years of the e.motion® PS Pro System.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient having signed informed consent * Patients over 18 for which a Total Knee Prosthesis with e.motion® PS Pro was decided * Patients willing to participate in a 5 years follow-up Exclusion Criteria: * Active or suspected infection * Tumor on the concerned knee * Patient vulnerable and under legal protection

What they're measuring

Survival rate at 5 years of the e motion PS Pro

Timeframe: the survival rate will be evaluated 6-12 weeks; 1; 2; 3; 4 and 5 years after the knee arthroplasty

Trial details

NCT IDNCT02934802

SponsorBBraun Medical SAS

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-02

Contact for this trial

François Boillot

144123357 fboillot@hpsj.fr

View on ClinicalTrials.gov More Knee Arthroplasty trials